TA

Tejas Ashesh Wankhede

Active Director Director DIN 10758367
DIN 10758367 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Tejas Ashesh Wankhede

Data last updated:

Tejas Ashesh Wankhede is a Director at Amoxis Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10758367
Primary Designation Director
Industry Pharma
First Appointment 29 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Aug 20242024Active

Board colleagues of Tejas Ashesh Wankhede

NameDINCompanyDesignation
Dheer Vishal Jain10439499Amoxis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Amoxis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tejas Ashesh Wankhede

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tejas Ashesh Wankhede

Tejas Ashesh Wankhede currently holds 1 directorship: Amoxis Pharmaceuticals Private Limited (Director, since 29 Aug 2024).

Tejas Ashesh Wankhede was first appointed on 29 Aug 2024 as Director at Amoxis Pharmaceuticals Private Limited.

The current boards of Tejas Ashesh Wankhede's companies include Dheer Vishal Jain (Amoxis Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available